Lance E. Steward

MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT

#2 | 2024-01-18

US20240018500A1

DEGRADABLE CLOSTRIDIAL TOXINS

#3 | 2023-10-19

US20230332126A1

Botulinum Neurotoxin Proteins and Methods to Engineer and Generate Same

#4 | 2023-10-12

US20230321420A1

MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT

#5 | 2023-09-28

US20230302103A1

BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN

#6 | 2022-01-13

US20220008702A1

MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT

#7 | 2021-06-03

US20210162027A1

BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN

#8 | 2020-06-18

US20200190496A1

DEGRADABLE CLOSTRIDIAL TOXINS

#9 | 2020-02-20

US20200054869A1

MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT

#10 | 2018-12-06

US20180344820A1

Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin

#11 | 2018-08-23

US20180236215A1

Microneedle array with active ingredient

#12 | 2018-05-03

US20180119126A1

Degradable clostridial toxins

#13 | 2016-11-03

US20160319265A1

Methods of intracellular conversion of single-chain proteins into their di-chain form

#14 | 2016-07-14

US20160201046A1

Degradable clostridial toxins

#15 | 2015-08-20

US20150232905A1

METHODS OF ACTIVATING CLOSTRIDIAL TOXINS

#16 | 2014-08-14

US20140227740A1

Degradable Clostridial toxins

#17 | 2014-08-07

US20140220627A1

Degradable clostridial toxins

#18 | 2014-05-08

US20140127784A1

MODIFIED CLOSTRIDIAL TOXINS COMPRISING AN INTEGRATED PROTEASE CLEAVAGE SITE-BINDING DOMAIN

#19 | 2014-05-08

US20140127783A1

Degradable clostridial toxins

#20 | 2014-01-30

US20140030759A1

Methods of intracellular conversion of single-chain proteins into their di-chain form

#21 | 2013-12-26

US20130345413A1

MODIFIED CLOSTRIDIAL TOXINS WITH ENHANCED TRANSLOCATION CAPABILITIY

#22 | 2013-12-12

US20130330807A1

Degradable clostridial toxins

#23 | 2013-12-12

US20130330806A1

Degradable clostridial toxins

#24 | 2013-10-31

US20130288336A1

METHODS OF ACTIVATING CLOSTRIDIAL TOXINS

#25 | 2013-10-31

US20130288334A1

Degradable clostridial toxins

#26 | 2013-10-24

US20130281666A1

METHODS OF ACTIVATING CLOSTRIDIAL TOXINS

#27 | 2013-10-17

US20130273633A1

Degradable clostridial toxins

#28 | 2013-09-19

US20130245227A1

METHODS OF ACTIVATING CLOSTRIDIAL TOXINS

#29 | 2013-08-29

US20130224178A1

Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases

#30 | 2013-08-08

US20130203148A1

Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity

#31 | 2013-08-01

US20130196414A1

Degradable clostridial toxins

#32 | 2013-08-01

US20130195838A1

Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases

#33 | 2012-11-22

US20120295330A1

Methods of intracellular conversion of single-chain proteins into their di-chain form

#34 | 2012-09-13

US20120231538A1

Lipophilic dye-based FRET assays for clostridial toxin activity

#35 | 2012-08-16

US20120207743A1

Inhibiting Aberrant Blood Vessel Formation Using Retargeted Endopeptidases

#36 | 2012-08-16

US20120207742A1

Treatments Using PSMA Ligand Endopeptidases

#37 | 2012-08-16

US20120207734A1

Methods of Inhibiting Aberrant Blood Vessel Formation Using Opioid Retargeted Endpeptidases

#38 | 2012-08-16

US20120207733A1

Treating a Disease of Hyperproliferation Using Retargeted Endopeptidases

#39 | 2012-08-16

US20120207704A1

Inhibiting Aberrant Blood Vessel Formation Using Growth Factor Retargeted Endopeptidases

#40 | 2012-07-12

US20120178140A1

Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systems

#41 | 2012-05-31

US20120135495A1

Neurotoxins with enhanced target specificity

#42 | 2012-05-10

US20120115205A1

Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs

#43 | 2012-03-01

US20120052548A1

Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells

#44 | 2011-12-01

US20110294742A1

DEGRADABLE CLOSTRIDIAL TOXINS

#45 | 2011-11-24

US20110287517A1

Degradable clostridial toxins

#46 | 2011-08-04

US20110189162A1

Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding Domain

#47 | 2011-05-12

US20110111483A1

Optimizing Expression of Active Botulinum Toxin Type E

#48 | 2011-05-12

US20110111479A1

Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs

#49 | 2011-03-24

US20110070621A1

Multivalent clostridial toxins

#50 | 2011-02-24

US20110046356A1

Post-translational modifications and Clostridial neurotoxins

#51 | 2010-11-11

US20100286371A1

Methods of activating clostridial toxins

#52 | 2010-11-04

US20100280222A1

CLOSTRIDIAL NEUROTOXIN COMPOSITIONS AND MODIFIED CLOSTRIDIAL NEUROTOXINS

#53 | 2010-10-28

US20100273986A1

Post-translation modification and clostridial neurotoxins

#54 | 2010-10-28

US20100273985A1

Post-translational modifications and clostridial neurotoxins

#55 | 2010-06-24

US20100160609A1

Chimera botulinum toxin type E

#56 | 2010-06-17

US20100151494A1

FRET protease assays for clostridial toxins

#57 | 2010-05-13

US20100121042A1

Nucleic acids encoding chimera botulinum toxin type E

#58 | 2010-04-01

US20100081158A1

FRET protease assays for clostridial toxins

#59 | 2010-04-01

US20100081157A1

FRET protease assays for clostridial toxins

#60 | 2010-03-25

US20100075396A1

Botulinum neurotoxin serotype B activatable Botulinum neurotoxin serotype Bs

#61 | 2010-03-25

US20100075358A1

Fret protease assays for clostridial toxins

#62 | 2010-03-25

US20100075357A1

FRET protease assays for clostridial toxins

#63 | 2010-03-25

US20100075346A1

FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS

#64 | 2010-03-18

US20100069610A1

Substrates useful for FRET protease assays for botulinum serotype A/E toxins

#65 | 2010-03-04

US20100055727A1

FRET protease assays for botulinum serotype A/E toxins

#66 | 2010-02-18

US20100041098A1

Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells

#67 | 2009-08-13

US20090202591A1

Leucine-based motif and clostridial neurotoxins

#68 | 2009-07-30

US20090191583A1

Clostridial toxin activity assays

#69 | 2009-05-07

US20090118475A1

Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins

#70 | 2009-05-07

US20090117572A1

Cell compositions useful for cell-based FRET assays for clostridial toxins

#71 | 2009-03-12

US20090069238A1

Activatable clostridial toxins

#72 | 2009-02-26

US20090053746A1

Fret protease assays for botulinum serotype A/E toxins

#73 | 2009-02-19

US20090048431A1

Multivalent clostridial toxins

#74 | 2009-02-17

US10757077

Modified botulinum neurotoxins

#75 | 2009-02-12

US20090042231A1

FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS

#76 | 2009-01-22

US20090023901A1

Degradable clostridial toxins

#77 | 2009-01-22

US20090023198A1

OPTIMIZING EXPRESSION OF ACTIVE BOTULINUM TOXIN TYPE A

#78 | 2009-01-15

US20090018081A1

ACTIVATABLE CLOSTRIDIAL TOXINS

#79 | 2009-01-01

US20090005313A1

ACTIVATABLE CLOSTRIDIAL TOXINS

#80 | 2009-01-01

US20090004225A1

TOXIN COMPOUNDS WITH ENHANCED MEMBRANE TRANSLOCATION CHARACTERISTICS

#81 | 2009-01-01

US20090004224A1

Activatable clostridial toxins

#82 | 2008-10-02

US20080241881A1

Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells

#83 | 2008-09-11

US20080221012A1

Activatable clostridial toxins

#84 | 2008-09-11

US20080220456A1

Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity

#85 | 2008-09-04

US20080214781A1

Leucine-based motif and clostridial neurotoxins

#86 | 2008-09-04

US20080213830A1

Degradable clostridial toxins

#87 | 2008-09-04

US20080213796A1

GFP-SNAP25 fluorescence release assay for botulinum toxin protease activity

#88 | 2008-08-14

US20080194797A1

Leucine-based motif and Clostridial neurotoxins

#89 | 2008-07-24

US20080177042A1

Leucine-based motif and clostridial neurotoxins

#90 | 2008-07-24

US20080177041A1

Leucine-based motif and clostridial neurotoxins

#91 | 2008-07-24

US20080177037A1

Leucine-based motif and clostridial neurotoxins

#92 | 2008-07-24

US20080176336A1

FRET PROTEASE ASSAYS FOR BOTULINUM SEROTYPE A/E TOXINS

#93 | 2008-07-24

US20080176249A1

GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity

#94 | 2008-07-17

US20080171348A1

GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity

#95 | 2008-07-10

US20080166739A1

GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity

#96 | 2008-07-03

US20080161543A1

Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells

#97 | 2008-07-03

US20080161226A1

Activatable clostridial toxins

#98 | 2008-07-03

US20080160561A1

Lipophilic dye-based fret assays for clostridal toxin activity

#99 | 2008-06-19

US20080146786A1

FRET protease assays for botulinum serotype A/E toxins

#100 | 2008-06-12

US20080138893A1